miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes

Background. Early diagnosis of ankylosing spondylitis (AS) is yet not elucidated, with a potential diagnostic glance of microRNAs (miRNAs). Aim. Study the expression profile of miRNA-451a and miRNA-125a in AS patients and their impact on disease activity and prognosis. Methods. A cross-sectional stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Dina Salem Fotoh, Rasha Ibrahim Noreldin, Mohamed Soliman Rizk, Maha Mohamed Elsabaawy, Heba Ahmed Esaily
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/2180913
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560239845572608
author Dina Salem Fotoh
Rasha Ibrahim Noreldin
Mohamed Soliman Rizk
Maha Mohamed Elsabaawy
Heba Ahmed Esaily
author_facet Dina Salem Fotoh
Rasha Ibrahim Noreldin
Mohamed Soliman Rizk
Maha Mohamed Elsabaawy
Heba Ahmed Esaily
author_sort Dina Salem Fotoh
collection DOAJ
description Background. Early diagnosis of ankylosing spondylitis (AS) is yet not elucidated, with a potential diagnostic glance of microRNAs (miRNAs). Aim. Study the expression profile of miRNA-451a and miRNA-125a in AS patients and their impact on disease activity and prognosis. Methods. A cross-sectional study included 55 AS patients diagnosed according to modified New York criteria in 1984 with 55 matched healthy controls. History, clinical examination, and disease activity assessment with Bath ankylosing spondylitis disease activity index (BASDAI) were done. Full laboratory and radiological assessment along with expression profile of m iRNA-451a and miRNA-125a were tabulated and analyzed. Results. Higher expression levels of miRNA-125a and lower of miRNA-451a in AS patients compared to controls. Furthermore, miRNA-125a expression was high in active AS patients compared to inactive patients and controls (7.0±3.4 vs. 4.1±2.1 vs. 2.6±0.6, p<0.001, respectively). miRNA-451a was significantly lower in active AS patients compared to inactive patients and controls (2.2±1.1 vs. 4.1±2.3 vs. 7.1±4.5, respectively). Both miRNAs (miRNA-125a and miRNA-451a) had evident accuracy for AS diagnosis with areas under the curve (AUC) of 0.788 and 0.802, respectively. miRNA-125a had potential impact on AS activity with AUC of 0.777. Plasma levels of both miRNAs were able to distinguish AS patients with structural damage with AUCs 0.775 and 0.692, respectively. Conclusions. Both miRNA-451a and miRNA-125a were found to be of great value as sensitive noninvasive diagnostic, prognostic, and disease burden biomarker of AS patients in Egypt with suggested further studies for future therapeutic implications.
format Article
id doaj-art-4606d30d971947d590a97209f39aeb84
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-4606d30d971947d590a97209f39aeb842025-02-03T01:28:07ZengWileyJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/21809132180913miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and OutcomesDina Salem Fotoh0Rasha Ibrahim Noreldin1Mohamed Soliman Rizk2Maha Mohamed Elsabaawy3Heba Ahmed Esaily4Physical Medicine, Rheumatology and Rehabilitation Department, Faculty of Medicine, Menoufia University, EgyptClinical Pathology Department, Faculty of Medicine, Menoufia University, EgyptMedical Biochemistry and Molecular Biology Department, Faculty of Medicine, Menoufia University, EgyptHepatology and Gastroenterology Department, National Liver Institute, Menoufia University, EgyptPhysical Medicine, Rheumatology and Rehabilitation Department, Faculty of Medicine, Menoufia University, EgyptBackground. Early diagnosis of ankylosing spondylitis (AS) is yet not elucidated, with a potential diagnostic glance of microRNAs (miRNAs). Aim. Study the expression profile of miRNA-451a and miRNA-125a in AS patients and their impact on disease activity and prognosis. Methods. A cross-sectional study included 55 AS patients diagnosed according to modified New York criteria in 1984 with 55 matched healthy controls. History, clinical examination, and disease activity assessment with Bath ankylosing spondylitis disease activity index (BASDAI) were done. Full laboratory and radiological assessment along with expression profile of m iRNA-451a and miRNA-125a were tabulated and analyzed. Results. Higher expression levels of miRNA-125a and lower of miRNA-451a in AS patients compared to controls. Furthermore, miRNA-125a expression was high in active AS patients compared to inactive patients and controls (7.0±3.4 vs. 4.1±2.1 vs. 2.6±0.6, p<0.001, respectively). miRNA-451a was significantly lower in active AS patients compared to inactive patients and controls (2.2±1.1 vs. 4.1±2.3 vs. 7.1±4.5, respectively). Both miRNAs (miRNA-125a and miRNA-451a) had evident accuracy for AS diagnosis with areas under the curve (AUC) of 0.788 and 0.802, respectively. miRNA-125a had potential impact on AS activity with AUC of 0.777. Plasma levels of both miRNAs were able to distinguish AS patients with structural damage with AUCs 0.775 and 0.692, respectively. Conclusions. Both miRNA-451a and miRNA-125a were found to be of great value as sensitive noninvasive diagnostic, prognostic, and disease burden biomarker of AS patients in Egypt with suggested further studies for future therapeutic implications.http://dx.doi.org/10.1155/2020/2180913
spellingShingle Dina Salem Fotoh
Rasha Ibrahim Noreldin
Mohamed Soliman Rizk
Maha Mohamed Elsabaawy
Heba Ahmed Esaily
miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
Journal of Immunology Research
title miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
title_full miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
title_fullStr miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
title_full_unstemmed miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
title_short miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
title_sort mirna 451a and mirna 125a expression levels in ankylosing spondylitis impact on disease diagnosis prognosis and outcomes
url http://dx.doi.org/10.1155/2020/2180913
work_keys_str_mv AT dinasalemfotoh mirna451aandmirna125aexpressionlevelsinankylosingspondylitisimpactondiseasediagnosisprognosisandoutcomes
AT rashaibrahimnoreldin mirna451aandmirna125aexpressionlevelsinankylosingspondylitisimpactondiseasediagnosisprognosisandoutcomes
AT mohamedsolimanrizk mirna451aandmirna125aexpressionlevelsinankylosingspondylitisimpactondiseasediagnosisprognosisandoutcomes
AT mahamohamedelsabaawy mirna451aandmirna125aexpressionlevelsinankylosingspondylitisimpactondiseasediagnosisprognosisandoutcomes
AT hebaahmedesaily mirna451aandmirna125aexpressionlevelsinankylosingspondylitisimpactondiseasediagnosisprognosisandoutcomes